中药汽雾透皮疗法用于外周静脉留置针静脉炎的临床护理价值分析

doi:10.3760/cma.j.cn441417-20240722-01030

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (1): 141-145.DOI: 10.3760/cma.j.cn441417-20240722-01030

中药汽雾透皮疗法用于外周静脉留置针静脉炎的临床护理价值分析

赵玉　刘兰克

杜鸽河南省中医院（河南中医药大学第二附属医院）麻醉科，郑州 450000

收稿日期:2024-07-22 出版日期:2025-01-01 发布日期:2025-01-14
通讯作者: 赵玉，Email：zhaoyuhns@163.com
基金资助:
河南省中医药科学研究专项课题（2023ZY2092）

Analysis of the clinical nursing value of Chinese medicine vapor-mist transdermal therapy for peripheral intravenous catheter phlebitis

Zhao Yu, Liu Lanke, Du Ge

Department of Anesthesiology, Henan Provincial Hospital of Traditional Chinese Medicine, The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, China

Received:2024-07-22 Online:2025-01-01 Published:2025-01-14
Contact: Zhao Yu, Email: zhaoyuhns@163.com
Supported by:
Special Subject of Scientific Research on Traditional Chinese Medicine in Henan Province (2023ZY2092)

摘要/Abstract

摘要：

目的　分析中药汽雾透皮疗法用于外周静脉留置针（PIVC）静脉炎的临床护理价值。方法　选取2022年1月至2023年12月河南省中医院收治的102例PIVC静脉炎患者作为研究对象。采用随机数字表法，将患者分为试验组（51例）和对照组（51例）。试验组男27例，女24例；年龄18～60（42.16±5.18）岁；静脉炎分级：Ⅲ级40例，Ⅳ级11例。对照组男26例，女25例；年龄18～60（42.03±5.11）岁；静脉炎分级：Ⅲ级41例，Ⅳ级10例。对照组采用常规中药外敷治疗，试验组采用中药汽雾透皮治疗。两组均连续治疗2 d。比较两组治疗效果、血管弹性恢复状况，治疗前和治疗后2 h、6 h、24 h疼痛程度［疼痛数字评分法（NRS）］，治疗前后炎症指标［超敏C反应蛋白（hs-CRP）、白细胞介素-6（IL-6）］。采用独立样本t检验和χ²检验进行统计学分析。结果　试验组治疗总有效率高于对照组［94.12%（48/51）比80.39%（41/51）］（P<0.05）；试验组血管弹性正常率高于对照组［78.43%（40/51）比47.06%（24/51）］（P<0.05）。治疗后2 h、6 h、24 h，试验组NRS评分均低于对照组［（3.58±0.31）分比（4.36±0.39）分、（2.77±0.25）分比（3.92±0.33）分、（1.95±0.17）分比（2.84±0.24）分］（均P<0.05）。治疗后，试验组hs-CRP、IL-6水平均低于对照组［（8.73±0.72）mg/L比（13.05±1.18）mg/L、（3.93±0.32）μg/L比（7.58±0.67）μg/L］（均P<0.05）。结论　中药汽雾透皮疗法可提高PIVC静脉炎患者治疗效果，加快血管弹性恢复速度，缓解机体疼痛，减轻炎症反应。

关键词:

外周静脉留置针, 静脉炎, 中药汽雾透皮疗法, 常规中药外敷

Abstract:

Objective　To analyze the clinical nursing value of Chinese medicine vapor-mist transdermal therapy for peripheral intravenous catheter (PIVC) phlebitis. Methods　A total of 102 patients with PIVC phlebitis treated in Henan Provincial Hospital of Traditional Chinese Medicine from January 2022 to December 2023 were selected as the study objects. The patients were divided into an experimental group (51 cases) and a control group (51 cases) by the random number table method. There were 27 males and 24 females in the experimental group, aged 18-60 (42.16±5.18) years, and the grade of phlebitis was grade Ⅲ in 40 cases and grade Ⅳ in 11 cases. There were 26 males and 25 females in the control group, aged 18-60 (42.03±5.11) years, and the grade of phlebitis was grade Ⅲ in 41 cases and grade Ⅳ in 10 cases. The control group took conventional traditional Chinese medicine topical treatment, and the experimental group took Chinese medicine vapor-mist transdermal therapy for 2 days. The treatment effect, vascular elasticity recovery status, pain degree before treatment and 2, 6, and 24 h after treatment [Numeric Rating Scale (NRS)], and inflammatory indexes before and after treatment [hypersensitive C-reactive protein (hs-CRP) and interleukin-6 (IL-6)] were compared between the two groups. Independent sample t test and χ² test were used for statistical analysis. Results　The total effective rate of the experimental group was higher than that of the control group [94.12% (48/51) vs. 80.39% (41/51)] (P<0.05). The normalization rate of vascular elasticity of the experimental group was higher than that of the control group [78.43% (40/51) vs. 47.06% (24/51)] (P<0.05). At 2 h, 6 h, and 24 h after treatment, the NRS scores of the experimental group were lower than those of the control group [(3.58±0.31) points vs. (4.36±0.39) points, (2.77±0.25) points vs. (3.92±0.33) points, (1.95±0.17) points vs. (2.84±0.24) points] (all P<0.05). After treatment, the levels of hs-CRP and IL-6 in the experimental group were lower than those in the control group [(8.73±0.72) mg/L vs. (13.05±1.18) mg/L, (3.93±0.32) μg/L vs. (7.58±0.67) μg/L] (both P<0.05). Conclusion　Chinese medicine vapor-mist transdermal therapy used in the clinical care of PIVC phlebitis can significantly improve the therapeutic effect, accelerate the recovery speed of vascular elasticity, relieve the pain of the body, and reduce the inflammatory response.

Key words:

Peripheral intravenous catheter, Phlebitis, Chinese medicine vapor-mist transdermal therapy, Conventional Chinese medicine external application

赵玉　刘兰克.

中药汽雾透皮疗法用于外周静脉留置针静脉炎的临床护理价值分析 [J]. 国际医药卫生导报, 2025, 31(1): 141-145.

Zhao Yu, Liu Lanke, Du Ge.

Analysis of the clinical nursing value of Chinese medicine vapor-mist transdermal therapy for peripheral intravenous catheter phlebitis [J]. International Medicine and Health Guidance News, 2025, 31(1): 141-145.

参考文献

[1] Tan YH, Tai WL, Sim C, et al. Optimising peripheral venous catheter usage in the general inpatient ward: a prospective observational study[J]. J Clin Nurs, 2017, 26(1-2):133-139. DOI: 10.1111/jocn.13451.
[2] 刘杰,王淑秀,邹娟,等.中药贴敷疗法治疗外周静脉留置针静脉炎的护理效果研究[J].系统医学,2021,6(16):155-158.DOI:10.19368/j.cnki.2096-1782.2021.16.155.
[3] Gras E, Jean A, Rocher V, et al. Incidence of and risk factors for local complications of peripheral venous catheters in patients older than 70 years: empirical research quantitative[J]. J Clin Nurs, 2023, 32(15-16):5000-5009. DOI: 10.1111/jocn.16732.
[4] 邹生燕,于啸.优化中药湿热敷技术在防治外周静脉留置针所致静脉炎护理中的应用效果[J].山西医药杂志,2020,49(14):1925-1927.DOI:10.3969/j.issn.0253-9926.2020. 14.059.
[5] 马建辉,王丽丽,曹东义.中药透皮疗法联合西药对类风湿关节炎活动期患者血清CD62p、CD41表达水平的影响[J].中国中西医结合杂志,2017,37(7):881-882.DOI:10.7661/j.cjim.20170426.118.
[6] 花冬兰,庄凤玲,沈蕾蕾,等.中药熏蒸联合脊柱推拿对颈椎失稳症患者疼痛及运动的影响[J].中国中医急症,2019,28(12):2214-2216.DOI:10.3969/j.issn.1004- 745X.2019.12.041.
[7] Gorski LA. The 2016 infusion therapy standards of practice[J]. Home Healthc Now, 2017, 35(1):10-18. DOI: 10.1097/NHH.0000000000000481.
[8] 王蔚文.临床疾病诊断与疗效判断标准[M].北京:科学技术文献出版社,2010:937.
[9] 陈杰,吴晓英,战颖,等.中文版成人疼痛行为量表的研制及信效度检验[J].中国疼痛医学杂志,2016,22(1):28-33.DOI:10.3969/j.issn.1006-9852.2016.01.007.
[10] 潘杰,苗秀欣,赵迪,等.3种外用药物预防静脉留置针输注营养液所致静脉炎的效果观察[J].中西医结合护理(中英文),2020,6(2):108-110.DOI:10.11997/nitcwm. 202002026.
[11] 吴玉梅.优化改进式护理干预降低新生儿静脉留置针致静脉炎发生率效果观察[J].齐鲁护理杂志,2017,23(24):107-109.DOI:10.3969/j.issn.1006-7256.2017.24.050.
[12] Igarashi A, Okuno T, Shimizu T, et al. Mechanical stimulation is a risk factor for phlebitis associated with peripherally inserted central venous catheter in neonates[J]. Pediatr Int, 2021, 63(5):561-564. DOI: 10.1111/ped.14476.
[13] 徐曼,陈小芬,张玉娟,等.胶体敷料代替薄膜敷贴固定静脉留置针对输注脂肪乳发生静脉炎的疗效观察[J].中国急救复苏与灾害医学杂志,2022,17(12):1642-1644.DOI:10.3969/j.issn.1673-6966.2022.12.027.
[14] 张彩琳,李婷,王娟,等.复方紫草通络散外用治疗静脉留置针静脉炎的效果观察[J].甘肃医药,2023,42(6):554-556.DOI:10.15975/j.cnki.gsyy.2023.06.013.
[15] 张玉霞,付朝阳,王海亚.降低新生儿静脉留置针导致静脉炎的护理干预[J].国际医药卫生导报,2016,22(5):706-708.DOI:10.3760/cma.j.issn.1007-1245.2016.05.038.
[16] 李瑞红,饶艳红,王筱锋.中药酒灸治疗外周静脉留置针静脉炎临床观察[J].光明中医,2019,34(1):90-92.DOI:10.3969/j.issn.1003-8914.2019.01.037.
[17] 底佳曼,常丽娟.中药外敷在静脉炎中的研究进展[J].全科护理,2022,20(22):3082-3084.DOI:10.12104/j.issn.1674- 4748.2022.22.014.
[18] 王利花.中药外敷联合自理学说干预在PICC置管致静脉炎护理中的应用[J].光明中医,2020,35(22):3653-3655.DOI:10.3969/j.issn.1003-8914.2020.22.060.
[19] 袁海蓉,周晓璇,刘志杰.优化中药湿热敷护理技术对外周静脉留置针所致静脉炎的防治效果分析[J].医学理论与实践,2022,35(8):1414-1416.DOI:10.19381/j.issn.1001- 7585.2022.08.069.
[20] 赵叶花.中药贴敷疗法治疗外周静脉留置针静脉炎的护理效果[J].中外医药研究,2022,1(17):94-96.DOI:10.3969/j.issn.1007-1180.2022.17.031.
[21] 邱雅婷,郭晶,叶真琪,等.金黄散外敷治疗外周静脉留置针所致静脉炎效果的Meta分析[J].循证护理,2020,6(11):1142-1148,1161.DOI:10.12102/j.issn.2095-8668.2020. 11.002.
[22] 陆佳敏,顾君娣,杨萍.自制"四妙中药敷贴"预防老年患者留置针输液性静脉炎的效果观察[J].浙江临床医学,2021,23(10):1521-1522.
[23] 蒋丹红.如意金黄散外敷预防静脉留置针并发静脉炎临床观察[J].新中医,2016,48(4):171-172.DOI:10.13457/j.cnki.jncm.2016.04.065.
[24] 孙苏苏,范卉.艾条灸联合金黄散外敷治疗老年患者静脉留置针所致静脉炎的疗效观察[J].中西医结合护理(中英文),2018,4(4):49-50.DOI:10.11997/nitcwm.201804014.
[25] 颜征,安震,张玥,等.联合中药外敷疗法治疗血栓性浅静脉炎有效性的Meta分析[J].中国中西医结合外科杂志,2022,28(5):650-654.DOI:10.3969/j.issn.1007-6948.2022. 05.011.

中药汽雾透皮疗法用于外周静脉留置针静脉炎的临床护理价值分析

Analysis of the clinical nursing value of Chinese medicine vapor-mist transdermal therapy for peripheral intravenous catheter phlebitis

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics